This episode of Expert Answers features Dr. Michael Czech, who recently joined us for a webinar to discuss a novel CRISPR-based cell therapy which enhances adipose tissue "browning" as a treatment for metabolic disease. Mke Czech is the Isadore and Fannie Foxman Professor at the University of Massachusetts Medical School, where he was founding Chair of the Program in Molecular Medicine. The Czech’s laboratory applies RNAi- and CRISPR-based technologies to address mechanisms of insulin signal transduction, metabolic regulation and insulin resistance in obesity and type 2 diabetes

For more information or to watch the webinar, click here.